Snapshot Of Attending Companies:

Navigating preclinical and translational challenges to ensure successful clinical development requires optimizing compounds for in vitro and in vivo studies, improving safety profiles, and advancing degrader design rationale. By addressing these hurdles, we can move closer towards safe and effective treatments

3rd Targeted Protein Degradation Europe Summit - Top Reasons to Attend

3rd Targeted Protein Degradation Summit Returns this March!

Join this exclusive three-day forum to explore the selectivity, bioavailability, and pharmacokinetic profile of TPD to guarantee safety, efficacy, and potency.

This community will spend 3 days be uncovering computational modelling of TPD, improving predictions and understanding target selectivity, along with optimizing degrader design via novel platform strategies.

Don't miss this fantastic opportunity to gain invaluable insights from top biopharma industry leaders!

Snapshot of the 30+ TPD Speaker Faculty

Group Discounts Available


To ensure the 3rd TPD Europe conference is as valuable to you and your team as possible, the 2022 programme boasts 2 dedicated streams of presentations to cater to all areas of expertise in the TPD field! 


Maximize your value for money using special team discounts:

10% discount - 3 delegates
15% discount - 4 delegates
20% discount - 5+ delegates

3rd TPD Europe Summit is Proud to Partner With:

SCIEX Logo Tag below 2019

Interested In Partnering? 

Contact: Jacob Roberts-Kendall, Senior Business Development Manager, Hanson Wade